Application no. and date | 14718815.5 (espacenet) (Federated) (European Patent Register), 20140311 | Patent/reg. no. and date | DK/EP 2967015, 20230607 | Publication date | 20160120 | Priority no. and date | US 201313793935, 20130311 | EP pub. no. and date |
EP 2967015 20160120 | Effective date | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road Tarrytown, NY 10591, US | Applicant ref. no. | | Inventor | MACDONALD, Lynn, c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road
Tarrytown, NY 10591, US, MURPHY, Andrew J., c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road
Tarrytown, NY 10591, US, STEVENS, Sean, 12848 Caminito De Las Olas
Del Mar, CA 92014, US, TU, Naxin, c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road
Tarrytown, NY 10591, US, GURER, Cagan, 21 Buttonhook Road
Chappaqua, NY 10514, US, VORONINA, Vera, 37 1/2 Amos Street
Sleepy Hollow, NY 10591, US | Representative | | Opponent | | IPC Class | A01K 67/027 (2006.01) , C07K 14/74 (2006.01) | Title | TRANSGENIC MICE EXPRESSING CHIMERIC MAJOR HISTOCOMPATIBILITY COMPLES (MHC) CLASS II MOLECULES | Int. application no. | US2014023068 | Int. publication no. | WO2014164638 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|